GSK seeks regulatory approval for Trelegy Ellipta and Zejula in Europe
GSK has also partnered with a consortium of non-profit organisations to advance the development of novel ‘pan-TB’ drug…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Feb 20
GSK has also partnered with a consortium of non-profit organisations to advance the development of novel ‘pan-TB’ drug…
27 Feb 20
Gilead has started the clinical studies, following the US Food and Drug Administration (FDA) acceptance of its investigational…
27 Feb 20
The sNDA approval was supported by the results from Phase 3 NALA trial, which evaluated the neratinib in…
26 Feb 20
Novartis will complete the Phase 1 clinical trials, while DNDi will lead Phase 2 and Phase 3 clinical…
25 Feb 20
Under the partnership, GSK will offer its pandemic adjuvant system to Clover for further evaluation of COVID-19 S-Trimer…
25 Feb 20
Perrigo has collaborated with its development and manufacturing partner Catalent Pharma Solutions to speed up the production
In clinical trials, the new IV treatment was shown to reduce symptoms of migraines — including headaches, nausea…
24 Feb 20
Trulicity is indicated for major adverse cardiovascular events (MACE) in type 2 diabetes patients, with cardiovascular (CV) disease…
24 Feb 20
The Phase 3 ATTRACTION-3 clinical trial, which evaluated Opdivo compared to chemotherapy, has supported the Japanese regulatory approval
21 Feb 20
The deal expands Lilly’s portfolio of medicines with the addition of lebrikizumabfor, for atopic dermatitis and QBREXZA for…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates